PPARα Agonist WY-14643 Induces SIRT1 Activity in Rat Fatty Liver Ischemia-Reperfusion Injury

Figure 1

WY-14643 pretreatment and sirtuins protein expression and activity in steatotic livers after ischemia-reperfusion. Western blot and densitometric analysis of (a) SIRT1 and (b) SIRT3. (c) SIRT1 enzymatic activity. Sham: anesthesia and laparotomy, IR: 60 min partial ischemia and 24 h of reperfusion, and WY-14643 + IR: iv administration of WY-14643 (10 mg/kg) 1 hour before IR. versus Sham; versus IR.

(a)

(b)

(c)